There was an allegation that one patient received repeatable false positive results from the elecsys anti-sars-cov-2 assay on unknown roche analyzers.The results did not agree with the clinical picture of the patient.Approximately 10 days prior to (b)(6) 2020, the patient reported a potential exposure to covid-19 through close interaction with a family member who had direct exposure to someone diagnosed with covid-19.The patient received a sars-cov-2 reverse transcription-polymerase chain reaction (rt-pcr) test using a self-administered throat swab that returned negative.On (b)(6) 2020, a sample from the patient was also evaluated using the elecsys anti-sars-cov-2 assay, resulting in a value of 3.51 coi (positive).Because the patient and her family received negative sars-cov-2 rna and antibody tests and showed no evidence of sars-cov-2 infection, the patient¿s immune response was re-evaluated on (b)(6) 2021 with a second serum specimen using the abbott architect i2000sr platform to test for plasma igg antibodies.This test returned a negative result.The first sample from (b)(6) 2020 was repeated with the elecsys anti-sars-cov-2 assay on (b)(6) 202, resulting in a value of 3.54 coi (positive).A third sample was collected from the patient on (b)(6) 2020 and portions of this sample were sent to two laboratories.Both laboratories tested the sample using the elecsys anti-sars-cov-2 assay, resulting in values of 3.36 coi (positive) and 3.6 coi (positive).One of the two laboratories also tested this sample using the abbott igg test, resulting in a value of 0.1 coi (negative).
|